Type 2 diabetes in youth is a rapidly rising, aggressive condition linked to increased adiposity. Early detection and treatment are critical for better outcomes. I’ll outline the current Australian guidelines to help clinicians identify high-risk individuals and navigate referral pathways to specialist teams. I’ll also briefly highlight the evidence for emerging pharmacotherapies and technologies in youth care.